Marion is a visionary pharmaceutical leader with over 15 years of experience in driving market expansion and operational excellence. Her career trajectory showcases a remarkable blend of legal expertise, political acumen, and pharmaceutical industry leadership.
As the founder of Linepharma and a key executive at Nordic Pharma, Marion has consistently demonstrated her ability to navigate complex global markets, particularly in women’s health. Her strategic initiatives have resulted in successful product launches across Europe, Australia, Canada, Latin America, and Africa, generating substantial revenue growth and improving access to critical healthcare solutions.
A true global leader, Marion has expertly managed cross-functional teams across diverse geographies, including the US, Canada, Japan, and Europe. Her expertise in maternal health, family planning, and reproductive health systems has been instrumental in developing and implementing innovative strategies for market penetration and expansion.
Marion’s educational background, combining law and political science from Université Sorbonne with finance and non-profit governance certifications, underpins her multifaceted approach to pharmaceutical leadership.
In 2023, Marion launched 49Care, further demonstrating her commitment to delivering high-quality healthcare products to women in Canada and reinforcing her dedication to innovation and growth in the pharmaceutical sector. She also serves on the boards of Options for Sexual Health and Women on Web.
Marion’s achievements have been widely recognized: she was named one of Canada’s Top 25 Women of Influence in 2025 and honored as Life Sciences Executive of the Year by the Canadian Healthcare Industry Awards.
